Aster DM Healthcare Ltd

Aster DM Healthcare has faced a significant decline in stock performance, marking eight consecutive days of losses and a cumulative drop of 16.68%. The company's stock is trading below multiple moving averages, with a notable 19.30% decrease over the past month, despite maintaining a high dividend yield of 30.22%.

Aster DM Healthcare's stock has declined for seven consecutive days, totaling a 13.2% drop. The company has underperformed its sector and reached an intraday low of Rs 417. Despite a high dividend yield of 29.17%, the stock has faced significant challenges in recent weeks.

Aster DM Healthcare's shares fell significantly today, continuing a trend of losses over the past week. The stock is currently above its 200-day moving average but below several shorter-term averages. Despite a high dividend yield, the company has struggled compared to broader market performance in recent weeks.

Aster DM Healthcare's shares have declined for four consecutive days, resulting in a total decrease of 6.69%. The stock underperformed compared to the broader sector and is currently positioned above its 200-day moving average but below several shorter-term averages. The company also offers a high dividend yield of 27.09%.

Aster DM Healthcare has announced its financial results for the quarter ending January 31, 2025, revealing a significant shift in performance for Q3 FY24-25. The company's score has undergone a notable adjustment, prompting a reassessment of its financial standing amid ongoing challenges in the healthcare sector.

Aster DM Healthcare has faced a significant decline in stock performance, marking three consecutive days of losses. The company's stock underperformed its sector and has seen a notable drop over the past month. Despite these challenges, it maintains a high dividend yield of 24.82%.

Aster DM Healthcare has recently experienced a score adjustment following a reassessment of its financial metrics and market position. The company reported flat financial performance in the latest quarter, with concerns regarding its return on capital employed and high debt-to-EBITDA ratio, despite some positive technical indicators.

Aster DM Healthcare's stock has declined for two consecutive days, dropping 3.86% overall. The company underperformed its sector and reached an intraday low of Rs 479.1. Despite this downturn, it maintains a high dividend yield of 24.55% and has seen a 6.78% decrease over the past month.

Aster DM Healthcare has recently experienced a change in evaluation, reflecting a detailed analysis of its financial metrics and market conditions. The company reported net sales of Rs 2,088.31 crore for Q2 FY24-25, alongside challenges such as a negative return on capital employed and a high debt-to-EBITDA ratio.

Aster DM Healthcare has recently experienced a change in evaluation, reflecting its current position amid market dynamics. The company reported net sales of Rs 2,088.31 crore for Q2 FY24-25, with a Return on Capital Employed of 9.68% and a Debt to EBITDA ratio of 3.19 times, indicating financial challenges.

Aster DM Healthcare has recently undergone a revision in its score, reflecting its strong market performance and resilience in the healthcare sector. The stock has been added to MarketsMOJO's list, highlighting its notable gains and consistent trading above key moving averages, appealing to investors seeking growth and income opportunities.

Aster DM Healthcare has been added to MarketsMOJO's list following a recent adjustment in its evaluation. The stock demonstrated notable gains, outperforming its sector and showcasing strong performance indicators, including a high dividend yield and consistent trading above key moving averages. This reflects a positive outlook for the company.

Aster DM Healthcare has been added to MarketsMOJO's list following a revision in its score. The stock is currently exhibiting positive technical trends, supported by strong financial metrics such as a notable Return on Capital Employed and impressive profit growth. However, challenges remain, including high debt levels and pledged promoter shares.

Aster DM Healthcare has recently experienced a revision in its score from MarketsMOJO, reflecting concerns over its long-term fundamental strength. Despite this adjustment, the stock remains in a mildly bullish technical range and offers an attractive valuation, high dividend yield, and significant growth potential, warranting careful investor consideration. In a recent analysis, Aster DM Healthcare, a prominent player in the hospital and healthcare services sector, has faced a downgrade in its evaluation from MarketsMOJO. This change stems from the company's weak long-term fundamentals, highlighted by a notably low Return on Capital Employed (ROCE) and a high Debt to EBITDA ratio, which raises concerns about its debt servicing capabilities. The latest financial results for September 2024 revealed flat performance, with a significant decline in net sales and the lowest operating cash flow recorded. Additionally, a concerning percentage of promoter shares are pledged, which could exert further pressure on stock prices in adverse market conditions. On a more positive note, the stock is currently positioned within a mildly bullish technical range, supported by favorable MACD and KST indicators. Its attractive valuation, combined with a high dividend yield, suggests potential for growth despite the recent downgrade. Investors are encouraged to weigh these factors carefully when considering their investment strategies regarding Aster DM Healthcare.

Aster DM Healthcare has experienced a revision in its stock evaluation following a recent decline. Despite a notable drop in performance, the stock remains above its moving averages and continues to offer a high dividend yield, making it a point of interest for investors. Additionally, it has been added to MarketsMOJO's list, highlighting its potential in the market.

Aster DM Healthcare has recently experienced a revision in its score, reflecting its strong market performance and positive trends. The stock has consistently outperformed its sector and the Sensex, showcasing significant gains over the past week. Additionally, it has been added to MarketsMOJO's list, highlighting its potential for growth.

Aster DM Healthcare, a leading hospital and healthcare services company, has seen a 3.04% increase in its stock performance on November 28, 2024. It has outperformed the sector by 3.86% and is trading higher than its moving averages. With a high dividend yield of 25.37%, it remains a top choice for investors.

Aster DM Healthcare, a leading hospital and healthcare services company, has seen a 5.06% increase in its stock performance on November 27, 2024, outperforming the sector by 3.76%. The stock has been on a consecutive gain for the last 4 days and is currently trading higher than its moving averages. With a high dividend yield of 27.6%, it is a favorable option for investors seeking stable returns. In comparison to the Sensex, Aster DM Healthcare has consistently shown better performance in the last month and continues to thrive in the industry.

Aster DM Healthcare, a largecap company in the hospital and healthcare services industry, has received a 'Hold' rating from MarketsMOJO due to its bullish trend and attractive valuations. However, the company's weak long-term fundamentals and high promoter pledged shares should also be considered before investing.